Whitehawk Therapeutics, Inc.
WHWK
$4.27
-$0.13-2.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.02% | 4.55% | -31.02% | 66.27% | -172.06% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -80.00% | -68.75% | -71.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.11% | 18.56% | -28.51% | -29.49% | 103.61% |
| Change in Net Operating Assets | 150.99% | -141.74% | 2,310.27% | 105.37% | -570.26% |
| Cash from Operations | 34.58% | -28.86% | -12.07% | 70.96% | -346.37% |
| Capital Expenditure | -- | -- | -- | 100.00% | 99.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 100.00% | -- | -100.00% |
| Other Investing Activities | -186.81% | 15.34% | 118.40% | -217.63% | -296.18% |
| Cash from Investing | -186.81% | 15.34% | 118.39% | -217.86% | -124.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -99.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 81.77% |
| Cash from Financing | -- | -- | -- | 100.00% | -100.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,915.84% | -665.29% | 99.66% | -29.49% | -141.56% |